Skip to main content
SpringerLink
Log in

Diet and Drugs for Hyperlipidaemia

  • Guest Editorial
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fredrickson, D.S.: Mutants, hyperlipoproteinaemia and coronary artery disease. British Medical Journal 2: 187 (1971).

    Article  PubMed  CAS  Google Scholar 

  2. Darmady, J.M.; Fosbrooke, A.S. and Lloyd, J.K.: Prospective study of serum cholesterol levels during first year of life. British Medical Journal 2: 685 (1972).

    Article  PubMed  CAS  Google Scholar 

  3. Gluek, C.J.; Ford, S.; Scheel, D. and Steiner, P.: Colestipol and cholestyramine resin. Journal of the American Medical Association 222: 676 (1972).

    Article  Google Scholar 

  4. Grundy, S.M.; Ahrens, E.H.; Salen, G.; Schreibman, P.H. and Nestel, P.J.: Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidaemia. Journal of Lipid Research 13: 531 (1972).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, School of Medicine, University of Auckland, Park Road, Auckland 3, New Zealand

    P. J. Scott

Authors
  1. P. J. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scott, P.J. Diet and Drugs for Hyperlipidaemia. Drugs 6, 1–6 (1973). https://doi.org/10.2165/00003495-197306010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197306010-00001

Search

Navigation